Chinenye O. Iwuji
Leicester, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Evaluating the Impact of Financial Navigation on Financial Catastrophe and Distress for Cancer Care: A Randomized Control Trial- COST-FIN.
Journal: Research square
Published: February 06, 2026
Evaluating the impact of financial navigation on financial catastrophe and distress for cancer care: a randomized control trial-COST-FIN.
Journal: Trials
Published: October 08, 2025
The State of Palliative Care in Nigeria: A Scoping Review.
Journal: Journal of pain and symptom management
Published: September 22, 2025
Barriers and facilitators of adoption and implementation of a financial navigation program: cost-fin trial.
Journal: Ecancermedicalscience
Published: June 18, 2025
Risk of financial catastrophe for breast cancer patients in Nigeria: A retrospective analysis.
Journal: American journal of surgery
Published: July 08, 2024
Catastrophic health expenditures for colorectal cancer care: A retrospective analysis of the first private comprehensive cancer center in Lagos, Nigeria.
Journal: American journal of surgery
Published: July 08, 2024
Biopsy for advanced hepatocellular carcinoma: results of a multicentre UK audit.
Journal: British journal of cancer
Published: June 11, 2021
Oncology practice in the COVID-19 pandemic: a report of a Nigerian expert panel discussion (oncology care in Nigeria during the COVID-19 pandemic).
Journal: The Pan African medical journal
Published: May 21, 2020
Curcumin Combined with FOLFOX Chemotherapy Is Safe and Tolerable in Patients with Metastatic Colorectal Cancer in a Randomized Phase IIa Trial.
Journal: The Journal of nutrition
Published: September 26, 2018
A multicentre comparison between Child Pugh and Albumin-Bilirubin scores in patients treated with sorafenib for Hepatocellular Carcinoma.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: January 29, 2016
Curcumin mediates oxaliplatin-acquired resistance reversion in colorectal cancer cell lines through modulation of CXC-Chemokine/NF-κB signalling pathway.
Journal: Scientific reports
Published: December 23, 2015
Curcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapy.
Journal: Cancer letters
Published: March 13, 2015
Last Updated: 09/26/2026